why am i not losing weight on semaglutide compounds (Ozempic/Wegovy)? Woman shares what happened after
Description
Obesity, diabetes, and increased cancer progression
95% CI [0.680.99])
h , placebo-corrected effects on fasting blood glucose
Overall, compared with the large and growing amount of pre-clinical and mechanistic evidence highlighting the reward-modulating and thus potentially anti-addictive properties of GLP-1RAs, only a few studies have investigated thus far the potential use of these medications in clinical populations with alcohol- or other substance-use disorders
The results also demonstrate meaningful improvements in blood sugar control
